Articles with public access mandates - David S. Goldfarb, MDLearn more
Not available anywhere: 12
Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease
SP Sedlis, CT Jurkovitz, PM Hartigan, DS Goldfarb, JD Lorin, M Dada, ...
The American journal of cardiology 104 (12), 1647-1653, 2009
Mandates: Canadian Institutes of Health Research
Feasibility and acceptability of mHealth interventions for managing hyperphosphatemia in patients undergoing hemodialysis
DE St-Jules, K Woolf, DS Goldfarb, ML Pompeii, H Li, C Wang, A Mattoo, ...
Journal of Renal Nutrition 31 (4), 403-410, 2021
Mandates: US National Institutes of Health
Institutional characteristics associated with receipt of emergency care for obstructive pyelonephritis at community hospitals
MS Borofsky, D Walter, H Li, O Shah, DS Goldfarb, RE Sosa, DV Makarov
The Journal of Urology 193 (3), 851-856, 2015
Mandates: US Department of Veterans Affairs
Uronephrology: a new nephrology subspecialty
DS Goldfarb
Current Opinion in Nephrology and Hypertension 29 (2), 199-200, 2020
Mandates: US National Institutes of Health
PD05-12 WHAT IS THE BEST PLANT-BASED YOGURT FOR PATIENTS WITH KIDNEY STONES AND/OR CHRONIC KIDNEY DISEASE?
J Borin, J Knight, R Holmes, S Joshi, D Goldfarb, W Lin, S Loeb
Journal of Urology 207 (Supplement 5), e90, 2022
Mandates: US National Institutes of Health
Primary Hyperoxaluria (PH) Types 1 and 2 with Kidney and/or Liver Transplant Achieve Best Health-Related Quality of Life (HRQoL): PO0416
F Modersitzki, DS Milliner, JC Lieske, DS Goldfarb
Journal of the American Society of Nephrology 31 (10S), 176-177, 2020
Mandates: US National Institutes of Health
Metabolic Investigations: When and in Whom
DS Goldfarb
Urinary Tract Stone Disease, 659-665, 2010
Mandates: US National Institutes of Health
Genotype-Phenotype Correlation in Cystinuria: SA-PO568
MD Hossain, AG Cogal, IE Porter, DS Goldfarb, PC Harris, JC Lieske
Journal of the American Society of Nephrology 33 (11S), 761, 2022
Mandates: US National Institutes of Health
High Prevalence of Kidney Cysts in Hereditary Hypophosphatemic Rickets with Hypercalciuria: PO1203
C Hanna, J Arroyo, P Tebben, VE Torres, PC Harris, DS Goldfarb, DJ Sas, ...
Journal of the American Society of Nephrology 32 (10S), 392, 2021
Mandates: US National Institutes of Health
Use of Tablo Hemodialysis Systems to Extend Dialytic Capabilities for the COVID-19-Associated Surge of AKI: PO0861
DS Goldfarb, JM Yan, MA Gross, CA Block
Journal of the American Society of Nephrology 31 (10S), 304, 2020
Mandates: US Department of Veterans Affairs
MP43-03 EFFECT OF INCREASING DOSES OF TIOPRONIN ON CYSTINE CAPACITY (CYSCAP) IN PATIENTS WITH CYSTINURIA
DS Goldfarb, K Rohit, F Modersitzki, P Quint, J Lieske, J Asplin
Journal of Urology 203, e647-e648, 2020
Mandates: US National Institutes of Health
Cystinuria: Assessing and Managing Risk
NT Sumorok, DS Goldfarb
Practical Controversies in Medical Management of Stone Disease, 105-114, 2014
Mandates: US National Institutes of Health
Available somewhere: 93
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
HJL Heerspink, HH Parving, DL Andress, G Bakris, R Correa-Rotter, ...
The Lancet 393 (10184), 1937-1947, 2019
Mandates: US Department of Veterans Affairs
Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment
YR Nobel, LM Cox, FF Kirigin, NA Bokulich, S Yamanishi, I Teitler, ...
Nature communications 6 (1), 7486, 2015
Mandates: US National Institutes of Health
Hereditary causes of kidney stones and chronic kidney disease
VO Edvardsson, DS Goldfarb, JC Lieske, L Beara-Lasic, F Anglani, ...
Pediatric nephrology 28, 1923-1942, 2013
Mandates: US National Institutes of Health
Crystal growth inhibitors for the prevention of L-cystine kidney stones through molecular design
JD Rimer, Z An, Z Zhu, MH Lee, DS Goldfarb, JA Wesson, MD Ward
Science 330 (6002), 337-341, 2010
Mandates: US National Institutes of Health
Pathophysiology and treatment of cystinuria
J Chillarón, M Font-Llitjós, J Fort, A Zorzano, DS Goldfarb, V Nunes, ...
Nature Reviews Nephrology 6 (7), 424-434, 2010
Mandates: US National Institutes of Health
Prevalence of contraindications and prescription of pharmacologic therapies for gout
RT Keenan, WR O'Brien, KH Lee, DB Crittenden, MC Fisher, DS Goldfarb, ...
The American journal of medicine 124 (2), 155-163, 2011
Mandates: US National Institutes of Health
Nutrient non-equivalence: does restricting high-potassium plant foods help to prevent hyperkalemia in hemodialysis patients?
DE St-Jules, DS Goldfarb, MA Sevick
Journal of Renal Nutrition 26 (5), 282-287, 2016
Mandates: US National Institutes of Health
Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy
K Kalantar-Zadeh, M Unruh, PG Zager, CP Kovesdy, JM Bargman, J Chen, ...
American Journal of Kidney Diseases 64 (2), 181-186, 2014
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program